Pheonix Research Publishes 2026 “Global Blood Group Typing Market Outlook – Press Release”
Global Blood Group Typing Market to Reach USD 4.60 Billion by 2033, Driven by Molecular Diagnostics and Rising Demand for Safe Transfusion Practices
March 2026 | Pheonix Research
The Global Blood Group Typing Market is projected to grow from USD 2.28 billion in 2025 to USD 4.60 billion by 2033, expanding at a CAGR of 9.17% during the forecast period, according to the latest analysis by Pheonix Research.
The market continues to benefit from increasing demand for safe blood transfusions, expanding surgical procedures, and the growing prevalence of chronic diseases worldwide. Rising healthcare investments and improvements in blood bank infrastructure are also strengthening the demand for advanced blood typing technologies across hospitals, diagnostic laboratories, and national blood donation programs.
Rachna Patni, Analyst – Healthcare & Diagnostics Industry at Pheonix Research, stated:
“The blood group typing market is evolving rapidly as healthcare systems prioritize precision diagnostics and transfusion safety. The integration of molecular diagnostic technologies such as next-generation sequencing and automated blood typing platforms is significantly improving testing accuracy and operational efficiency across blood banks and clinical laboratories.”
Key Market Highlights:
North America remains the largest regional market, supported by advanced healthcare infrastructure, strong regulatory oversight, and widespread adoption of automated blood typing systems.
Asia-Pacific is emerging as the fastest-growing region, driven by expanding healthcare access, increasing surgical volumes, and government initiatives to strengthen national blood donation programs.
Advanced diagnostic technologies including next-generation sequencing (NGS), PCR-based typing, and microarray platforms are improving accuracy and enabling identification of rare blood groups.
Growing demand for prenatal testing, organ transplantation compatibility screening, and transfusion safety protocols is accelerating adoption of high-precision blood typing solutions.
Technological transformation is reshaping diagnostic workflows across healthcare institutions. Automated analyzers, AI-assisted diagnostics, and high-throughput molecular typing platforms are enabling faster results while minimizing the risk of transfusion-related complications.
The competitive landscape remains moderately consolidated, with major players focusing on product innovation, strategic acquisitions, and expansion of diagnostic portfolios. Leading companies including BD (Becton, Dickinson and Company), Bio-Rad Laboratories, Quidel Ortho Corporation, Grifols, and Thermo Fisher Scientific continue to strengthen their market positions through advanced diagnostic platforms and global distribution networks.
As healthcare systems increasingly emphasize precision medicine and patient safety, the market is expected to witness continued investment in molecular diagnostics, automation technologies, and AI-driven laboratory solutions.
Pheonix Research’s latest report provides in-depth insights into market trends, regional dynamics, competitive benchmarking, and long-term growth opportunities across the Global Blood Group Typing Market.
📈 For a detailed look at the full report, visit:
👉 https://www.pheonixresearch.com/healthcare/diagnostics/market-report/global-blood-group-typing-market/
About Pheonix Research
Pheonix Research is a global market intelligence and strategic advisory firm delivering data-driven insights across healthcare, diagnostics, and other high-growth industries. Through advanced forecasting tools and AI-backed analytics, the firm supports stakeholders in identifying emerging opportunities and achieving sustainable competitive advantage.
Media Contact:
Pheonix Research
Email: Media@pheonixresearch.com
Website: www.pheonixresearch.com